Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-09

Clinical Trial Update: Trodat 1 SPECT and Dopamine Polymorphism

View source ↗

Summary

Clinical trial NCT01381302 evaluating Trodat 1 SPECT imaging and dopamine polymorphism in Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trodat 1 SPECT

Snippet

Sponsor: Wolfson Medical Center | Conditions: Parkinson Disease | Status: COMPLETED